Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7 - 36amide]) in patients with NIDDM. - Nauck,M.A.; Wollschlager,D.; Werner,J.; Holst,J.J.; Ørskov,C.; Creutzfeldt,W.; Willms,B. (Diabetologia, 1996)